37229259|t|Modulation of gut microbiota alleviates cerebral ischemia/reperfusion injury in rats by inhibiting M1 polarization of microglia.
37229259|a|Gut microbiota affects the gut-brain axis; hence, the modulation of the microbiota has been proposed as a potential therapeutic strategy for cerebral ischemia/reperfusion injury (CIRI). However, the role and mechanism of the gut microbiota in regulating microglial polarization during CIRI remain poorly understood. Herein, using a middle cerebral artery occlusion and reperfusion (MCAO/R) rat model, we evaluated changes in the gut microbiota after CIRI and the potential effects of fecal microbiota transplant (FMT) on the brain. Rats underwent either MCAO/R or sham surgery, and then they received FMT (started 3 days later; continued for 10 days). 2,3,5-Triphenyltetrazolium chloride staining, neurological outcome scale, and Fluoro-Jade C staining showed that MCAO/R induced cerebral infarction, neurological deficits, and neuronal degeneration. In addition, immunohistochemistry or real-time PCR assay showed increased expression levels of M1-macrophage markers-TNF-alpha, IL-1beta, IL-6, and iNOS-in the rats following MCAO/R. Our finding suggests that microglial M1 polarization is involved in CIRI. 16 S ribosomal RNA gene sequencing data revealed an imbalance in the gut microbiota of MCAO/R animals. In contrast, FMT reversed this MCAO/R-induced imbalance in the gut microbiota and ameliorated nerve injury. In addition, FMT prevented the upregulation in the ERK and NF-kappaB pathways, which reversed the M2-to-M1 microglial shift 10 days after MCAO/R injury in rats. Our primary data showed that the modulation of the gut microbiota can attenuate CIRI in rats by inhibiting microglial M1 polarization through the ERK and NF-kappaB pathways. However, an understanding of the underlying mechanism requires further study.
37229259	40	76	cerebral ischemia/reperfusion injury	Disease	MESH:D015427
37229259	80	84	rats	Species	10116
37229259	270	306	cerebral ischemia/reperfusion injury	Disease	MESH:D015427
37229259	308	312	CIRI	Disease	MESH:D015427
37229259	414	418	CIRI	Disease	MESH:D015427
37229259	461	493	middle cerebral artery occlusion	Disease	MESH:D020244
37229259	511	515	MCAO	Disease	
37229259	519	522	rat	Species	10116
37229259	579	583	CIRI	Disease	MESH:D015427
37229259	661	665	Rats	Species	10116
37229259	683	687	MCAO	Disease	
37229259	688	689	R	Disease	MESH:C580424
37229259	781	816	2,3,5-Triphenyltetrazolium chloride	Chemical	MESH:C009591
37229259	859	872	Fluoro-Jade C	Chemical	MESH:C534582
37229259	894	898	MCAO	Disease	
37229259	899	900	R	Disease	MESH:C580424
37229259	909	928	cerebral infarction	Disease	MESH:D002544
37229259	930	951	neurological deficits	Disease	MESH:D009461
37229259	957	978	neuronal degeneration	Disease	MESH:D009410
37229259	1097	1106	TNF-alpha	Gene	24835
37229259	1108	1116	IL-1beta	Gene	24494
37229259	1118	1122	IL-6	Gene	24498
37229259	1128	1132	iNOS	Gene	24599
37229259	1140	1144	rats	Species	10116
37229259	1155	1159	MCAO	Disease	
37229259	1231	1235	CIRI	Disease	MESH:D015427
37229259	1324	1328	MCAO	Disease	
37229259	1371	1375	MCAO	Disease	
37229259	1376	1377	R	Disease	MESH:C580424
37229259	1434	1446	nerve injury	Disease	MESH:D000080902
37229259	1499	1502	ERK	Gene	24338
37229259	1586	1590	MCAO	Disease	
37229259	1591	1599	R injury	Disease	MESH:C580424
37229259	1603	1607	rats	Species	10116
37229259	1689	1693	CIRI	Disease	MESH:D015427
37229259	1697	1701	rats	Species	10116
37229259	1755	1758	ERK	Gene	24338
37229259	Association	MESH:D015427	24338

